Synlogic achieves second research milestone under Roche IBD collaboration

SYNLOGIC, INC.

Second pre-specified milestone earned; milestone payment triggered under Roche collaboration.
First milestone was achieved and payment earned in September 2021.
Collaboration Agreement signed June 2021; Roche has exclusive option to negotiate a license after research period.

item 8.01

SYNLOGIC, INC. filing history →

Source: SEC EDGAR

accession 0001193125-22-238450

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.